David Gaugh | Association for Accessible Medicines
AAM Statement - President Trump’s Blueprint to Lower Drug Prices

David Gaugh

Senior Vice President, Sciences & Regulatory Affairs
David Gaugh, R.Ph.

David Gaugh has over 25 years of leadership experience in the health care and pharmaceutical business.

He joined the Association for Accessible Medicines in 2012 as the Senior Vice President for Sciences and Regulatory Affairs, where he is responsible for the professional liaison functions between member companies, agencies of the U.S. government and legislative bodies for all responsible areas. Prior to joining AAM, David was Vice President and General Manager of Bedford Laboratories, a Division of Ben Venue Laboratories and a wholly owned subsidiary of Boehringer Ingelheim.

David was previously the Senior Director, Pharmacy Contracting and Marketing at VHA/Novation (now Vizient). Before joining VHA/Novation, David was System Director of Pharmacy for St. Luke’s Health-System, a tertiary-care hospital in Kansas City, MO.

David is a registered pharmacist and has been engaged in several board-level pharmacy-related activities such as the American Society of Health-system Pharmacists Education and Research Foundation Board of Directors, USP Council of Convention, and American Foundation for Pharmaceutical Education Board of Directors.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.